We don't know whether the most recent response to this request contains information or not – if you are BEN HOLDSWORTH please sign in and let everyone know.

Melanoma Patients

BEN HOLDSWORTH made this Freedom of Information request to Orkney NHS Board as part of a batch sent to 93 authorities This request has been closed to new correspondence. Contact us if you think it should be reopened.

We're waiting for BEN HOLDSWORTH to read recent responses and update the status.

BEN HOLDSWORTH
Delivered

Dear Orkney NHS Board,

The following questions are being asked for on behalf of Novartis. The purpose of these questions is to understand the variability of treatment within your trust and in context to the rest of the country.

Q1. In the past 3 months (or the latest 3 months data you have available), how many melanoma patients were treated with:
• Bevacizumab (Avastin)
• Dacarbazine (DTIC)
• Trametinib (Mekinist)
• Dabrafenib (Tafinlar)
• Ipilimumab (Yervoy)
• Vemurafenib (Zelboraf)
• Nivolumab (Opdivo)
• Nivolumab + Ipilimumab (Opdivo + Yervoy)
• Pembrolizumab (Keytruda)
• Vemurafenib + cobimetinib (Zelboraf + Cotellic)
• Dabrafenib + Trametinib (Tafinlar + Mekinist)
• Braftovi (encorafenib) in combination with Mektovi (binimetinib) for BRAF V600 patients
• Other active systemic anti-cancer therapy [please state]
• Palliative care only

Q2. In the past 3 months (or the latest 3 months data you have available), how many metastatic melanoma patients were treated with the following:
• Ipilimumab
• Ipilimumab AND Nivolumab
• Nivolumab
• Pembrolizumab
• Dabrafenib AND Trametinib
• Any Other Targeted Therapy (Dabrafenib /Encorafenib AND Binimetinib /Trametinib /Vemurafenib /Vemurafenib AND Cobimetinib)
• Other active systemic anti-cancer therapy
• Palliative care only

Sincerely thank you for taking the time and resources to answer these questions.

Yours faithfully,

Ben Holdsworth

Link to this Report
ORK FOIrequests, Orkney NHS Board

FOI Request – Acknowledgement of Receipt
I hereby acknowledge receipt of the request below:

Reference number allocated to this request:
202223-225
(Please quote this reference number in any future correspondence relating to this request.)
The official date of your request is:
24/08/2022
A response should be sent to your request no later than:
21/09/2022

Note: NHS Orkney is a small remote and rural health board within Scotland. All responses to Freedom of Information requests are collated in accordance with the terms of the Freedom of Information (Scotland) Act 2002.

The Freedom of Information (Scotland) Act 2002 states that a public authority must inform the applicant in writing whether it holds the requested information and if so, communicate that information to the applicant, promptly, but not later than 20 working days after receipt of the request.

For further details please refer to The Scottish Information Commissioner’s website.

Sent by:
Freedom of Information Office
NHS Orkney
The Balfour,
Foreland Road,
Kirkwall,
KW15 1NZ

show quoted sections

Link to this Report
ORK FOIrequests, Orkney NHS Board

1 Attachment

Dear Mr.Holdsworth,

Please find attached the response from NHS Orkney to your FOI request.

Kind regards, Jenna

Jenna Johnston
Freedom of Information (FOI) Officer
The Balfour, Foreland Road, Kirkwall, KW15 1NZ
Tel: 01856 888220
FOI Requests e-mail: [email address]
Subject Access Requests e-mail: [email address]

Please note days of work: Monday and Thursday

show quoted sections

Link to this Report
We don't know whether the most recent response to this request contains information or not – if you are BEN HOLDSWORTH please sign in and let everyone know.